Wird geladen...
Denosumab – a new medication in the treatment of postmenopausal osteoporosis
Osteoporosis is a chronic, systemic skeletal disorder characterised by decreased bone density. It leads to an increased risk of bone fractures – one of the major causes of disability in modern societies. Bisphosphonates are the most commonly used medications in the treatment of postmenopausal osteop...
Gespeichert in:
| Veröffentlicht in: | Prz Menopauzalny |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Termedia Publishing House
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834919/ https://ncbi.nlm.nih.gov/pubmed/29507572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pm.2017.70581 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|